Effects of Systemic Immunosuppression on Islet Engraftment and Function Into a Subcutaneous Biocompatible Device

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 352-353

  Marzorati, S ^a   Bocca, N ^a   Molano, R D ^a   Hogan, A R ^a   Doni, M ^a,b   Cobianchi, L ^a,b   Inverardi, L ^a   Ricordi, C ^a   Pileggi, A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEVICE; DIABETES MELLITUS; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT DYSFUNCTION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD GLUCOSE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS TRANSPLANTATION; RATS; RATS, INBRED LEW; SIROLIMUS; TACROLIMUS; TRANSPLANTATION, ISOGENEIC;

EID: 60649104668     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.09.057     Document Type: Article

References (4)

1. Pileggi A., Cobianchi L., Inverardi L., et al. Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach. Ann NY Acad Sci 1079 (2006) 383
2. Zahr E., Molano R.D., Pileggi A., et al. Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation 84 (2007) 1576
3. Pileggi A., Molano R.D., Ricordi C., et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81 (2006) 1318
4. Bocca N., Pileggi A., Molano R.D., et al. Soft corticosteroids for local immunosuppression: exploring the possibility for the use of loteprednol etabonate for islet transplantation. Pharmazie 63 (2008) 226